US drugs giant Merck & Co. has signed a definitive agreement to acquire publicly traded US biotech Acceleron Pharma for $180 per share, yielding a total equity value of...
In conjunction with its American Rescue Plan, the administration of US president Joe Biden has announced its intention to spend $3 billion on building a stockpile of...
As India’s Covid-19 infections soar and the death toll nears 200,000, wealthier countries – including the US, UK, Germany, France and Australia – are rushing supplies of...
With some potential Covid-19 vaccine makers suggesting they could have a candidate ready for approval and maybe even deployment this autumn, concerns are arising that a...
03.06.2020
- In the latest round of the trademark battle between Merck & Co of the US (known outside North America as MSD) and Germany’s Merck KGaA (which trades in North America as EMD), the...
28.05.2020
- US pharma giant Merck & Co is wading into the race to find a vaccine or treatment for Covid-19. The New Jersey-based company is joining forces with nonprofit research group IAVI on...
20.04.2020
- The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...
